Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited, often referred to simply as Botanix, is an innovative biopharmaceutical company headquartered in Australia. Founded in 2016, the company focuses on developing novel therapies for skin diseases and other medical conditions, leveraging the therapeutic potential of cannabinoids. With a strong operational presence in Australia and the United States, Botanix is at the forefront of cannabinoid-based medicine. The company’s core products include its proprietary formulations designed to treat conditions such as acne and psoriasis, setting it apart in the competitive dermatology market. Botanix has achieved significant milestones, including successful clinical trials that underscore its commitment to advancing cannabinoid research. With a growing portfolio and a focus on scientific excellence, Botanix Pharmaceuticals is positioned as a leader in the emerging field of cannabinoid therapeutics.
DitchCarbon Score
How does Botanix Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Botanix Pharmaceuticals Limited's score of 14 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Botanix Pharmaceuticals Limited's reported carbon emissions
Botanix Pharmaceuticals Limited, headquartered in Australia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Botanix Pharmaceuticals may not yet have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. As the industry increasingly prioritises climate action, it will be essential for Botanix to consider developing and communicating its environmental strategies to align with global standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Botanix Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
